Feed Top Reports Pricing

⌘K

16:15:21·29d

SECFiling

SEC Form 10-K filed by Equillium Inc.

EQ· Equillium Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

EQ
Equillium Inc.
Health Care

Recent analyst ratings

Apr 23UpdateOppenheimer$7.00
Apr 16UpdateB. Riley Securities$6.00
Apr 14UpdateRaymond James$6.00
Apr 7UpdateCantor Fitzgerald$10.00
Mar 13UpdateRoth Capital$12.00
Feb 25UpdateStifel$5.00

Related

ANALYST15h
Oppenheimer initiated coverage on Equillium with a new price target
PR3d
Equillium to Participate in Oppenheimer's 2026 Innovation on the Island Event
SEC6d
SEC Form EFFECT filed by Equillium Inc.
ANALYST7d
B. Riley Securities initiated coverage on Equillium with a new price target
SEC8d
SEC Form DEFA14A filed by Equillium Inc.
SEC8d
SEC Form DEF 14A filed by Equillium Inc.
ANALYST9d
Raymond James initiated coverage on Equillium with a new price target
PR15d
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022